Mohamed Yassin
Hamad Medical Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mohamed Yassin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:03 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03548766 · Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood DopingHamad Medical Corporation · unknown · Blood Disease, Blood Transfusion, Autologous, Blood Doping · principal investigator
- N/ANCT03141398 · Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology GroupHamad Medical Corporation · withdrawn · Iron Overload, Hemoglobinopathies, Lymphoma · principal investigator
- N/ANCT03121599 · 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative NeoplasmsHamad Medical Corporation · terminated · Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage · principal investigator
- Ph3NCT03040765 · Denosumab Versus Zoledronic Acid in Thalassemia-Induced OsteoporosisHamad Medical Corporation · terminated · Thalassemia Majors (Beta-Thalassemia Major), Osteoporosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:03 UTC. The ranking covers the 200 most relevant of 18 PubMed records, and a shared surname and initials can bring in a namesake. All 18 on PubMed
- Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial.Stem Cell Res Ther · 2018149 citationsRCR 8.4
- LED fluorescence microscopy for the diagnosis of pulmonary tuberculosis: a multi-country cross-sectional evaluation.PLoS Med · 201158 citationsRCR 2.2
- A multi-country non-inferiority cluster randomized trial of frontloaded smear microscopy for the diagnosis of pulmonary tuberculosis.PLoS Med · 201151 citationsRCR 1.8
- 34 citationsRCR 1.3
- Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis.Trop Med Int Health · 201028 citationsRCR 0.8
- 25 citationsRCR 1.2
- Gut priming with bovine colostrum and T regulatory cells in preterm neonates: a randomized controlled trial.Pediatr Res · 202122 citationsRCR 2.0
- The value of ethambutol in the treatment of tuberculous meningitis.J Trop Med Hyg · 197614 citationsRCR 0.9
- Obstetric vesico-vaginal fistula repair: should we trim the fistula edges? A randomized prospective study.Neurourol Urodyn · 201113 citationsRCR 0.7
- Rifampicin in the treatment of tuberculous meningitis.J Trop Med Hyg · 197813 citationsRCR 0.6